The global transcatheter heart valve market was valued at nearly USD 1.93 billion in 2015 and is expected to reach over USD 8.62 billion by 2024. The key reasons attributing to the high growth include the upsurge in the prevalence of valvular heart diseases amongst the population above 65 years of age, introduction of third-generation transcatheter heart valves, and favorable reimbursement policies in the U.S. and European Union (EU) nations.
Details
- Publication Date
- Jul 10, 2019
- Language
- English
- Category
- Science & Medicine
- Copyright
- All Rights Reserved - Standard Copyright License
- Contributors
- By (author): Carol Miller
Specifications
- Format